Mantle Cell Lymphoma Care From Diagnosis Through Relapse: Expert Guidance on Applying the Latest Evidence

Explore key issues in the management of MCL in this comprehensive program designed to keep you abreast of rapidly evolving treatment strategies. Gain insights on new developments as they emerge with the CME-certified interactive module, downloadable slideset, short expert commentaries, and an Interactive Decision Support Tool that lets you compare your treatment choices for MCL patient scenarios you enter with those of 5 experts.
Stephen Ansell, MD, PhD
Christopher R. Flowers, MD, MS
John P. Leonard, MD
Julie M. Vose, MD, MBA
Michael Wang, MD

ClinicalThought: MCL Management

Induction therapy in mantle cell lymphoma is rapidly evolving. How do you treat your patients with MCL?

Julie M. Vose, MD, MBA Released: April 30, 2018

Ibrutinib and acalabrutinib are both active in relapsed MCL. Read how I consider safety, long-term data, and patient preferences when deciding between these BTK inhibitors.

Christopher R. Flowers, MD, MS Released: August 10, 2018

Module

Review practical guidance and the most recent data in this expert analysis of challenging MCL cases, including discussions on when to initiate therapy, how to select optimal first-line treatment, and what to do at progression.

Stephen Ansell, MD, PhD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: November 13, 2018 Expiration: November 12, 2019

Downloadable Slideset

Download the slides from our online module to review expert guidance and recent for management of patients with MCL, including when to initiate therapy and how to select optimal treatment for individual patients.

Stephen Ansell, MD, PhD Released: November 13, 2018

Interactive Decision Support Tool

Use this Interactive Decision Support Tool to compare your choice of therapy for patients with newly diagnosed and relapsed/refractory mantle cell lymphoma with those of 5 renowned experts.

Stephen Ansell, MD, PhD Christopher R. Flowers, MD, MS John P. Leonard, MD Julie M. Vose, MD, MBA Michael Wang, MD Released: February 27, 2019
Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

This activity is supported by educational grants from
AbbVie
AstraZeneca
Pharmacyclics Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?